These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33743303)

  • 1. Additional characterization of LEF1 expression in nodular lymphocyte predominant Hodgkin lymphoma and classic Hodgkin lymphoma.
    Rea B; Bailey NG
    Ann Diagn Pathol; 2021 Jun; 52():151730. PubMed ID: 33743303
    [No Abstract]   [Full Text] [Related]  

  • 2. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
    Churchill HR; Roncador G; Warnke RA; Natkunam Y
    Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma.
    Lyapichev KA; Sakhdari A; Khoury JD; O'Malley DP; El Hussein S; Yin CC; Patel KP; Thakral B; Young KH; Medeiros LJ; Konoplev S
    Ann Diagn Pathol; 2020 Dec; 49():151636. PubMed ID: 32977233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma.
    Ravindran A; Kurtin PJ; King RL; Yuan J; Feldman AL; Rech KL; McPhail ED; Parikh SA; Ding W; Shi M
    Hum Pathol; 2022 Jul; 125():2-10. PubMed ID: 35421421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of c-FLIP in classic and nodular lymphocyte-predominant Hodgkin lymphoma.
    Uherova P; Olson S; Thompson MA; Juskevicius R; Hamilton KS
    Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):105-10. PubMed ID: 15354734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma.
    Ally F; Gajzer D; Fromm JR
    Clin Lab Med; 2023 Sep; 43(3):427-444. PubMed ID: 37481321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediastinal large B cell lymphoma.
    Martig DS; Fromm JR
    Cytometry B Clin Cytom; 2022 Jan; 102(1):14-25. PubMed ID: 34878224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metachronous and clonally related classic Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma.
    Ding Y; Campbell A; Zhang X; Fu K; Yuan J
    Pathology; 2021 Feb; 53(2):285-288. PubMed ID: 32951907
    [No Abstract]   [Full Text] [Related]  

  • 9. Validation of CD137 Immunohistochemical Stain on Paraffin-Embedded Tissue as a Marker to Facilitate Distinction Between Classic Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma, T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, and Anaplastic Large Cell Lymphoma.
    Carbone PN; Zhang QY
    Arch Pathol Lab Med; 2019 Mar; 143(3):280-281. PubMed ID: 30816829
    [No Abstract]   [Full Text] [Related]  

  • 10. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
    Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodular lymphocyte predominant Hodgkin lymphoma: diagnostic pearls and pitfalls.
    Smith LB
    Arch Pathol Lab Med; 2010 Oct; 134(10):1434-9. PubMed ID: 20923296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of composite classical and nodular lymphocyte predominant Hodgkin lymphoma with progression to diffuse large B-cell non-Hodgkin lymphoma: Diagnostic difficulty in fine-needle aspiration cytology.
    Das DK; Sheikh ZA; Al-Shama'a MH; John B; Alawi AM; Junaid TA
    Diagn Cytopathol; 2017 Mar; 45(3):262-266. PubMed ID: 27888658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities.
    Tousseyn TA; King RL; Fend F; Feldman AL; Brousset P; Jaffe ES
    Virchows Arch; 2023 Jan; 482(1):207-226. PubMed ID: 36274093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
    Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
    Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
    Barber NA; Loberiza FR; Perry AM; Bast M; Holdeman KP; Esfahane AB; Weisenburger DD; Vose J; Bierman P; Armitage JO; Bociek RG
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow Cytometric Detection of the Double-Positive (CD4+CD8+)/PD-1bright T-Cell Subset Is Useful in Diagnosing Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    Chen ZW; Wizniak J; Shang C; Lai R
    Arch Pathol Lab Med; 2022 Jun; 146(6):718-726. PubMed ID: 34506624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular lymphocyte-predominant Hodgkin lymphoma and T cell histiocyte-rich large B cell lymphoma: diagnosis in two monozygotic twins.
    Cano I; Lozano M; Rodríguez A; Mate A; Adrados M; López Mdel M; Carro R; Montes-Moreno S
    Histopathology; 2010 Jul; 57(1):159-62. PubMed ID: 20653789
    [No Abstract]   [Full Text] [Related]  

  • 19. Nodular lymphocyte-predominant Hodgkin lymphoma.
    Savage KJ; Mottok A; Fanale M
    Semin Hematol; 2016 Jul; 53(3):190-202. PubMed ID: 27496311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modern principles in the management of nodular lymphocyte-predominant Hodgkin lymphoma.
    Spinner MA; Varma G; Advani RH
    Br J Haematol; 2019 Jan; 184(1):17-29. PubMed ID: 30485408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.